Microbiology

CLSI AST Beta-Lactam Webinar

Exploring Beta-Lactam Combination Agents: Opportunities, Gaps, and Challenges

Join us for an insightful on-demand webinar exploring the challenges and successes of using beta-lactam combination agents from three unique perspectives: the pharmaceutical industry, the laboratory, and clinical practice. This discussion will cover the development process of beta-lactam combination agents, laboratory requests and quality control (QC) issues, as well as the practical successes and limitations of using these agents in clinical settings.

June 22, 2024
1.50

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Scope

Learning Objectives

  1. Describe the process in development of beta-lactam combination agents. 
  2. Recognize requests that laboratories receive for testing these agents. 
  3. Identify challenges laboratories face with QC issues when testing beta-lactam combination agents. 
  4. Summarize the success and failures of using beta-lactam combination agents in clinical practice.

Advanced: Highly technical. For those with current skills/knowledge and extensive experience in a specialty area.

CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Speakers
Greg Moeck, PhD, Senior Vice President, Microbiology at Venatorx Pharmaceuticals, Inc.
Romney Humphries, PhD, D(ABMM), M(ASCP), Professor, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center
Andrew Fratoni, PharmD, Associate Director, Clinical and Laboratory Studies, Hartford Hospital
Stella Antonara, PhD, D(ABMM), Medical Director of Microbiology, OhioHealth
Scope

Learning Objectives

  1. Describe the process in development of beta-lactam combination agents. 
  2. Recognize requests that laboratories receive for testing these agents. 
  3. Identify challenges laboratories face with QC issues when testing beta-lactam combination agents. 
  4. Summarize the success and failures of using beta-lactam combination agents in clinical practice.

Advanced: Highly technical. For those with current skills/knowledge and extensive experience in a specialty area.

CLSI is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Speakers
Greg Moeck, PhD, Senior Vice President, Microbiology at Venatorx Pharmaceuticals, Inc.
Romney Humphries, PhD, D(ABMM), M(ASCP), Professor, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center
Andrew Fratoni, PharmD, Associate Director, Clinical and Laboratory Studies, Hartford Hospital
Stella Antonara, PhD, D(ABMM), Medical Director of Microbiology, OhioHealth